Trial Profile
A Study to Evaluate Effect of Transitioning Patients With Pulmonary Arterial Hypertension (PAH) from Inhaled Prostacyclin to Oral Prostacyclin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- 07 Mar 2016 New trial record